CID 3051693

4-morpholinesulfonamide, n-((8-beta)-9,10-didehydro-6-methylergolin-8-yl)methyl)-

Structural Information

Molecular Formula
C20H26N4O3S
SMILES
CN1C[C@@H](C=C2[C@H]1CC3=CNC4=CC=CC2=C34)CNS(=O)(=O)N5CCOCC5
InChI
InChI=1S/C20H26N4O3S/c1-23-13-14(11-22-28(25,26)24-5-7-27-8-6-24)9-17-16-3-2-4-18-20(16)15(12-21-18)10-19(17)23/h2-4,9,12,14,19,21-22H,5-8,10-11,13H2,1H3/t14-,19+/m0/s1
InChIKey
OLSAIERDYJKXEW-IFXJQAMLSA-N
Compound name
N-[[(6aR,9R)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]methyl]morpholine-4-sulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

1
Patents

402.17258 Da
Monoisotopic Mass

0.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 403.17986 190.2
[M+Na]+ 425.16180 196.1
[M-H]- 401.16530 192.9
[M+NH4]+ 420.20640 200.1
[M+K]+ 441.13574 191.1
[M+H-H2O]+ 385.16984 181.9
[M+HCOO]- 447.17078 194.9
[M+CH3COO]- 461.18643 197.3
[M+Na-2H]- 423.14725 194.2
[M]+ 402.17203 189.6
[M]- 402.17313 189.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe